Anti驨 and anti驞oa immunoglobulin G alloantibody–mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with …
A Unnikrishnan, JPR Pelletier, S Bari, M Zumberg… - …, 2019 - Wiley Online Library
BACKGROUND Delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis is a
potentially fatal complication resulting from alloimmunization that can cause severe …
potentially fatal complication resulting from alloimmunization that can cause severe …
Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with …
A Unnikrishnan, JPR Pelletier, S Bari, M Zumberg… - Transfusion, 2019 - europepmc.org
Background Delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis is a
potentially fatal complication resulting from alloimmunization that can cause severe …
potentially fatal complication resulting from alloimmunization that can cause severe …
Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with …
A Unnikrishnan, JPR Pelletier, S Bari… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis is a
potentially fatal complication resulting from alloimmunization that can cause severe …
potentially fatal complication resulting from alloimmunization that can cause severe …